Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.13 +0.12 (+2.99%)
At close: Oct 1, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Return on Equity [ROE] (2018 - 2026)

Updated

Adial Pharmaceuticals' Return on Equity [ROE] was -163.92% in Q1 2026, up 125.16 percentage points from -289.08% a year earlier but down 7.53 percentage points from the prior quarter.

Analysis

Adial Pharmaceuticals (ADIL) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Adial Pharmaceuticals came in at -163.72%, up 160.08 percentage points from FY2024.

  • Return on Equity [ROE] shows a five-year change of +32.08 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -323.80% in FY2024 (-184.58 pp), -139.22% in FY2023 (+236.10 pp), -375.32% in FY2022 (+143.06 pp) and -518.38% in FY2021 (-322.58 pp).
  • Quarterly Return on Equity [ROE] has moved between -502.69% (Q1 2023) and -156.06% (Q3 2025) over five years.
  • Compared with a year earlier, Return on Equity [ROE] has increased for four straight quarters, with an average year-over-year change of +16.42 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2024 (a gain of 332.30 percentage points); the worst was Q1 2023 (a drop of 255.18 percentage points).
  • Per Business Quant data, ADIL's Return on Equity [ROE] in the three quarters before Q1 2026 was -156.39% (Q4 2025), -156.06% (Q3 2025) and -216.50% (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Adial Pharmaceuticals 18.53 Mn 18.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -163.92%
Dec 31, 2025 -156.39%
Sep 30, 2025 -156.06%
Jun 30, 2025 -216.50%
Mar 31, 2025 -289.08%
Dec 31, 2024 -265.23%
Sep 30, 2024 -256.82%
Jun 30, 2024 -235.42%
Mar 31, 2024 -170.39%
Dec 31, 2023 -159.54%
Sep 30, 2023 -203.40%
Jun 30, 2023 -290.89%
Mar 31, 2023 -502.69%
Dec 31, 2022 -273.01%
Sep 30, 2022 -227.84%
Jun 30, 2022 -182.10%
Mar 31, 2022 -247.50%
Dec 31, 2021 -364.54%
Sep 30, 2021 -283.67%
Jun 30, 2021 -307.85%
API Access

Adial Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ADIL&period=max&api_key=YOUR_API_KEY